PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 43 filers reported holding PROQR THRAPEUTICS N V in Q3 2020. The put-call ratio across all filers is 6.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $617,000 | +57.4% | 93,400 | 0.0% | 0.00% | – |
| Q4 2020 | $392,000 | -14.2% | 93,400 | -2.1% | 0.00% | – |
| Q3 2020 | $457,000 | -9.5% | 95,400 | +14.8% | 0.00% | – |
| Q2 2020 | $505,000 | +85.0% | 83,100 | +66.9% | 0.00% | – |
| Q1 2020 | $273,000 | -44.7% | 49,800 | 0.0% | 0.00% | – |
| Q4 2019 | $494,000 | +425.5% | 49,800 | +382.4% | 0.00% | – |
| Q2 2019 | $94,000 | -78.5% | 10,324 | -67.2% | 0.00% | -100.0% |
| Q1 2019 | $437,000 | -33.8% | 31,497 | -24.7% | 0.00% | 0.0% |
| Q4 2018 | $660,000 | – | 41,840 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 1,237,400 | $5,197,000 | 1.55% |
| Prosight Management, LP | 255,000 | $1,071,000 | 0.50% |
| RTW INVESTMENTS, LP | 5,009,768 | $21,041,000 | 0.35% |
| Kerrisdale Advisers, LLC | 453,182 | $1,903,000 | 0.15% |
| Artal Group S.A. | 1,196,218 | $5,024,000 | 0.11% |
| COWEN AND COMPANY, LLC | 285,696 | $1,200,000 | 0.11% |
| Golden Green, Inc. | 16,999 | $71,000 | 0.07% |
| APOGEM CAPITAL LLC | 15,855 | $67,000 | 0.04% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4,550,062 | $19,110,000 | 0.04% |
| ALTRINSIC GLOBAL ADVISORS LLC | 241,360 | $1,014,000 | 0.03% |